OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
217058

Alujain Corp

Commodity ChemicalsVerified

Alujain Corp's capital structure is characterized by a low debt-to-equity ratio of 0.01, indicating a conservative leverage profile. The company maintains a strong liquidity position with a current ratio of 3.65 and holds SAR 110 million in cash and equivalents. However, its free cash flow is negative at SAR -1.74 billion, driven by a capital expenditure of SAR -469 million. Profitability metrics are sharply negative, with a return on equity of -33.25% and a return on assets of -21.09%. These figures fall well below the typical performance of the Commodity Chemicals industry, which is known for volatile margins and cyclical demand. The company reported a net loss of SAR 834 million for the period, with operating income also in negative territory at SAR -1.34 billion. Geographically, Alujain Corp's revenue is concentrated in the Middle East, with Saudi Arabia being the primary market. The company does not disclose detailed segment data, but its operations are largely focused on commodity chemicals, which are subject to global price fluctuations and raw material costs. The company's growth trajectory is currently constrained by declining profitability and negative cash flow. While capital expenditures are relatively modest, the lack of positive operating cash flow suggests the company is not generating sufficient internal funds to support expansion. Analysts have assigned a mean price target of SAR 34.00, with a single "buy" recommendation and no "strong buy" ratings. Risk factors include exposure to volatile commodity prices and potential regulatory changes in the Middle East. The company has no immediate filing-based liquidity or dilution flags, and its dilution potential is assessed as low. However, the negative net income and operating cash flow raise concerns about long-term sustainability. Recent filings and transcripts do not indicate any major strategic shifts or capital-raising activities. The company's financial performance is in line with broader industry challenges, including rising input costs and weak demand in key markets.

30-day price · 2170(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyAlujain Corp
Ticker2170.SE
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Alujain Corp is a Saudi Arabian chemicals company that produces and distributes commodity chemicals, primarily serving industrial and construction markets.

Classification. Alujain Corp is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

Alujain Corp's capital structure is characterized by a low debt-to-equity ratio of 0.01, indicating a conservative leverage profile. The company maintains a strong liquidity position with a current ratio of 3.65 and holds SAR 110 million in cash and equivalents. However, its free cash flow is negative at SAR -1.74 billion, driven by a capital expenditure of SAR -469 million. Profitability metrics are sharply negative, with a return on equity of -33.25% and a return on assets of -21.09%. These figures fall well below the typical performance of the Commodity Chemicals industry, which is known for volatile margins and cyclical demand. The company reported a net loss of SAR 834 million for the period, with operating income also in negative territory at SAR -1.34 billion. Geographically, Alujain Corp's revenue is concentrated in the Middle East, with Saudi Arabia being the primary market. The company does not disclose detailed segment data, but its operations are largely focused on commodity chemicals, which are subject to global price fluctuations and raw material costs. The company's growth trajectory is currently constrained by declining profitability and negative cash flow. While capital expenditures are relatively modest, the lack of positive operating cash flow suggests the company is not generating sufficient internal funds to support expansion. Analysts have assigned a mean price target of SAR 34.00, with a single "buy" recommendation and no "strong buy" ratings. Risk factors include exposure to volatile commodity prices and potential regulatory changes in the Middle East. The company has no immediate filing-based liquidity or dilution flags, and its dilution potential is assessed as low. However, the negative net income and operating cash flow raise concerns about long-term sustainability. Recent filings and transcripts do not indicate any major strategic shifts or capital-raising activities. The company's financial performance is in line with broader industry challenges, including rising input costs and weak demand in key markets.
Key takeaways
  • Alujain Corp is operating at a significant loss, with a return on equity of -33.25% and a return on assets of -21.09%.
  • The company maintains a strong liquidity position with a current ratio of 3.65 and SAR 110 million in cash and equivalents.
  • Free cash flow is negative at SAR -1.74 billion, driven by capital expenditures and weak operating performance.
  • Analysts have assigned a mean price target of SAR 34.00, with only one "buy" recommendation and no "strong buy" ratings.
  • The company's financial performance is in line with broader industry challenges, including rising input costs and weak demand in key markets.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencySAR
Revenue$1.30B
Gross profit-$49.6M
Operating income-$1.34B
Net income-$833.9M
R&D
SG&A
D&A
SBC
Operating cash flow$177.7M
CapEx-$469.2M
Free cash flow-$1.74B
Total assets$3.95B
Total liabilities$1.45B
Total equity$2.51B
Cash & equivalents$110.0M
Long-term debt$16.1M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$1.30B-$1.34B-$833.9M-$1.74B
FY-1$1.56B-$104.7M-$50.7M-$458.0M
FY-2$1.40B$18.6M-$82.2M$5.2M
FY-3$1.91B$166.5M$64.5M$154.1M
FY-4$519.3M$330.7M$1.62B$1.58B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$3.95B$2.51B$110.0M
FY-1$5.48B$3.49B
FY-2$4.62B$3.03B$95.0M
FY-3$4.80B$2.58B$101.5M
FY-4$5.20B$2.61B$100.0M
PeriodOCFCapExFCFSBC
FY0$177.7M-$469.2M-$1.74B
FY-1$197.6M-$597.3M-$458.0M
FY-2$416.7M-$191.6M$5.2M
FY-3$355.0M-$132.5M$154.1M
FY-4$333.1M-$20.0M$1.58B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$365.5M$12.3M$12.2M-$88.8M
FQ-1$326.8M-$1.31B-$845.4M-$1.43B
FQ-2$364.1M$4.2M$16.4M$10.5M
FQ-3$342.9M$4.1M$12.4M-$64.8M
FQ-4$267.7M-$41.5M-$17.2M-$155.6M
FQ-5$358.1M-$158.7M-$116.8M-$340.2M
FQ-6$338.2M$5.8M$45.8M-$75.3M
FQ-7$380.8M$27.5M$14.6M$6.5M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$4.21B$2.47B$402.4M
FQ-1$3.95B$2.51B$148.8M
FQ-2$5.55B$3.35B$412.2M
FQ-3$5.31B$3.38B$222.5M
FQ-4$5.36B$3.48B$340.3M
FQ-5$5.48B$3.49B$589.2M
FQ-6$5.53B$3.61B$950.6M
FQ-7$5.57B$3.56B$1.03B
PeriodOCFCapExFCFSBC
FQ0$80.5M-$89.5M-$88.8M
FQ-1$177.7M-$469.2M-$1.43B
FQ-2$61.7M-$357.3M$10.5M
FQ-3$68.8M-$298.4M-$64.8M
FQ-4-$11.9M-$169.5M-$155.6M
FQ-5$197.6M-$597.3M-$340.2M
FQ-6$201.0M-$374.4M-$75.3M
FQ-7$123.5M-$190.1M$6.5M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$2.51B
Net cash$93.9M
Current ratio3.6
Debt/Equity0.0
ROA-21.1%
ROE-33.2%
Cash conversion-21.0%
CapEx/Revenue-36.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric2170Activity
Op margin-103.2%0.4% medp25 -8.0% · p75 16.0%bottom quartile
Net margin-64.1%2.3% medp25 -11.6% · p75 11.8%bottom quartile
Gross margin-3.8%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-36.0%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity1.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Mean price target34.00 SAR
Median price target34.00 SAR
High price target34.00 SAR
Low price target34.00 SAR
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate1.08 SAR
Last actual EPS5.36 SAR
Source: analysis-pipeline (hybrid)Generated: 2026-05-19 00:14 UTCJob: 243c4b28